NTAW Holdings (ASX:NTD) continues reshaping its tyre and wheel distribution business following a challenging period for automotive demand. The company has focused on strengthening its operating platform, improving margins and reducing financial pressure while positioning its core business for a more sustainable recovery.
Duxton Farms (ASX:DBF) continues developing its position as an Australian agricultural asset company, with a strategy focused on owning and operating diversified farming assets across multiple agricultural sectors.
Nickel Industries (ASX:NIC) continues strengthening its position as an Indonesia-focused nickel producer, with the company pursuing growth through increased production, downstream integration and a move towards higher-value nickel products.
Sky Metals (ASX:SKY) continues progressing its Tallebung tin-tungsten-silver project in central New South Wales, with the company focused on expanding its resource base and advancing development studies.
INOVIQ (ASX:IIQ) continues advancing its life-sciences platform focused on exosome-based diagnostics and therapeutic applications, with the company targeting opportunities in cancer detection and precision medicine.
Delta Lithium (ASX:DLI) continues developing its position within Western Australia’s lithium sector, with the company focused on advancing its flagship projects while maintaining financial flexibility during a challenging period for battery minerals markets.
Great Dirt Resources (ASX:GR8) continues developing its battery minerals exploration portfolio, with the company pursuing opportunities across manganese and lithiumAssetsin Australia. The explorer is focused on advancing early-stage projects that provide exposure to commodities linked to long-term energy transition and industrial demand.
Lac Gold (ASX:LAC) continues developing its gold exploration strategy through the Rouyn Gold Project in Quebec, Canada, with the company focused on expanding its resource base and unlocking further exploration potential.
Argenica Therapeutics (ASX:AGN) continues developing its neuroprotection platform, with the company focused on advancing ARG-007 (xaranetide) across potential applications in stroke and traumatic brain injury. The Perth-based biotechnology company is working to translate its scientific research into therapies targeting conditions where significant unmet medical …
VEEM (ASX:VEE) continues to position itself for longer-term growth through its marine engineering and defence manufacturing capabilities. The Perth-based company produces specialised marine products including propulsion systems, propellers and gyrostabilisers, while also supplying solutions into defence-related markets.